|
Berry, V., Magill, A., Yost, M., Janosky, J., & Sindhi, R. (2006). Individualizing combination of two antiproliferative immunosuppressants with pharmacodynamic modeling of stimulated lymphocyte responses. Cytometry Part A, 69A(2), 95-103. doi:10.1002/cyto.a.20200
Biswas, S., Biswas, K., Richmond, A., Ko, J., Ghosh, S., Simmons, M., . . . Finke, J. H. (2009). Elevated levels of select gangliosides in T cells from renal cell carcinoma patients is associated with T cell dysfunction. J Immunol, 183(8), 5050-5058. doi:10.4049/jimmunol.0900259
Boccuto, L., Aoki, K., Flanagan-Steet, H., Chen, C. F., Fan, X., Bartel, F., . . . Schwartz, C. E. (2014). A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation. Hum Mol Genet, 23(2), 418-433. doi:10.1093/hmg/ddt434
Burnet, M. (1957). Cancer: a biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications. British medical journal, 1(5023), 841-847. doi:10.1136/bmj.1.5023.841
Capello, M., Vykoukal, J. V., Katayama, H., Bantis, L. E., Wang, H., Kundnani, D. L., . . . Hanash, S. M. (2019). Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity. Nature Communications, 10(1), 254. doi:10.1038/s41467-018-08109-6
Chen, Y.-X., Chen, X.-W., Li, C.-G., Yue, L.-J., Mai, H.-R., & Wen, F.-Q. (2013). Effect of tumor gangliosides on tyrosine phosphorylation of p125FAK in platelet adhesion to collagen. Oncology reports, 29(1), 343-348.
Cheung, N. K., Lazarus, H., Miraldi, F. D., Abramowsky, C. R., Kallick, S., Saarinen, U. M., . . . Berger, N. A. (1987). Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma. Journal of Clinical Oncology, 5(9), 1430-1440. doi:10.1200/jco.1987.5.9.1430
D'Angelo, G., Capasso, S., Sticco, L., & Russo, D. (2013). Glycosphingolipids: synthesis and functions. The FEBS journal, 280(24), 6338-6353.
Dolo, V., Li, R., Dillinger, M., Flati, S., Manela, J., Taylor, B. J., . . . Ladisch, S. (2000). Enrichment and localization of ganglioside GD3 and caveolin-1 in shed tumor cell membrane vesicles. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1486(2), 265-274. doi:https://doi.org/10.1016/S1388-1981(00)00063-9
Edwards, J., Wilmott, J. S., Madore, J., Gide, T. N., Quek, C., Tasker, A., . . . Palendira, U. (2018). CD103(+) Tumor-Resident CD8(+) T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti-PD-1 Treatment. Clin Cancer Res, 24(13), 3036-3045. doi:10.1158/1078-0432.Ccr-17-2257
Esplugues , E., Sancho , D., Vega-Ramos , J., Martínez-A , C., Syrbe , U., Hamann , A., . . . Lauzurica , P. (2003). Enhanced Antitumor Immunity in Mice Deficient in CD69. Journal of Experimental Medicine, 197(9), 1093-1106. doi:10.1084/jem.20021337
Han, Y., Jia, L., Zheng, Y., & Li, W. (2018). Salivary Exosomes: Emerging Roles in Systemic Disease. International Journal of Biological Sciences, 14(6), 633-643. doi:10.7150/ijbs.25018
Jones, J. D., Hamilton, B. J., Skopelja, S., & Rigby, W. F. C. (2014). Induction of interleukin-6 production by rituximab in human B cells. Arthritis & rheumatology (Hoboken, N.J.), 66(11), 2938-2946. doi:10.1002/art.38798
Khan, A. R., Hams, E., Floudas, A., Sparwasser, T., Weaver, C. T., & Fallon, P. G. (2015). PD-L1hi B cells are critical regulators of humoral immunity. Nature Communications, 6(1), 5997. doi:10.1038/ncomms6997
Kimata, H., & Yoshida, A. (1996). Inhibition of spontaneous immunoglobulin production by ganglioside GM2 in human B cells. Clin Immunol Immunopathol, 79(2), 197-202.
Klein-Schneegans, A.-S., Kuntz, L., Fonteneau, P., & Loor, F. (1989). Serum concentrations of IgM, IgG1, IgG2b, IgG3 and IgA in C57BL6 mice and their congenics at the lpr (lymphoproliferation) locus. Journal of Autoimmunity, 2(6), 869-875. doi:https://doi.org/10.1016/0896-8411(89)90013-9
Knaul, J. K., Jörg, S., Oberbeck-Mueller, D., Heinemann, E., Scheuermann, L., Brinkmann, V., . . . Dorhoi, A. (2014). Lung-residing myeloid-derived suppressors display dual functionality in murine pulmonary tuberculosis. Am J Respir Crit Care Med, 190(9), 1053-1066. doi:10.1164/rccm.201405-0828OC
Knutson, K. L., & Disis, M. L. (2005). Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunol Immunother, 54(8), 721-728. doi:10.1007/s00262-004-0653-2
Kong, Y., Li, R., & Ladisch, S. (1998). Natural forms of shed tumor gangliosides. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1394(1), 43-56. doi:https://doi.org/10.1016/S0005-2760(98)00096-4
Ladisch, S., Becker, H., & Ulsh, L. (1992). Immunosuppression by human gangliosides: I. Relationship of carbohydrate structure to the inhibition of T cell responses. Biochim Biophys Acta, 1125(2), 180-188. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1571361
Ladányi, A., Somlai, B., Gilde, K., Fejös, Z., Gaudi, I., & Tímár, J. (2004). T-Cell Activation Marker Expression on Tumor-Infiltrating Lymphocytes As Prognostic Factor in Cutaneous Malignant Melanoma. Clinical Cancer Research, 10(2), 521. doi:10.1158/1078-0432.CCR-1161-03
Lardone, R., Cely, I., Sieling, P., & Lee, D. (2014). Immune response modulation by tumor-secreted glycosphingolipids. J Glycobiol, 3(1), 107.
Ma, N., Fang, Y., Xu, R., Zhai, B., Hou, C., Wang, X., . . . Wang, R. (2019). Ebi3 promotes T- and B-cell division and differentiation via STAT3. Molecular Immunology, 107, 61-70. doi:https://doi.org/10.1016/j.molimm.2019.01.009
Maeda, K., Mehta, H., Drevets, D. A., & Coggeshall, K. M. (2010). IL-6 increases B-cell IgG production in a feed-forward proinflammatory mechanism to skew hematopoiesis and elevate myeloid production. Blood, 115(23), 4699-4706. doi:10.1182/blood-2009-07-230631
Marimpietri, D., Petretto, A., Raffaghello, L., Pezzolo, A., Gagliani, C., Tacchetti, C., . . . Pistoia, V. (2013). Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progression. PLoS One, 8(9), e75054-e75054. doi:10.1371/journal.pone.0075054
Moon, H. B., Severinson, E., Heusser, C., Johansson, S. G., Möller, G., & Persson, U. (1989). Regulation of IgG1 and IgE synthesis by interleukin 4 in mouse B cells. Scand J Immunol, 30(3), 355-361. doi:10.1111/j.1365-3083.1989.tb01221.x
Nagafuku, M., Okuyama, K., Onimaru, Y., Suzuki, A., Odagiri, Y., Yamashita, T., . . . Inokuchi, J.-i. (2012). CD4 and CD8 T cells require different membrane gangliosides for activation. Proceedings of the National Academy of Sciences, 109(6), E336. doi:10.1073/pnas.1114965109
Nishimura, T., Iwakabe, K., Sekimoto, M., Ohmi, Y., Yahata, T., Nakui, M., . . . Ohta, A. (1999). Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo. The Journal of experimental medicine, 190(5), 617-627. doi:10.1084/jem.190.5.617
Pardoll, D. M., & Topalian, S. L. (1998). The role of CD4+ T cell responses in antitumor immunity. Current Opinion in Immunology, 10(5), 588-594. doi:https://doi.org/10.1016/S0952-7915(98)80228-8
Pieper, K., Grimbacher, B., & Eibel, H. (2013). B-cell biology and development. Journal of Allergy and Clinical Immunology, 131(4), 959-971. doi:https://doi.org/10.1016/j.jaci.2013.01.046
Portoukalian, J., David, M.-J., Richard, M., & Gain, P. (1993). Shedding of GD2 ganglioside in patients with retinoblastoma. International Journal of Cancer, 53(6), 948-951. doi:10.1002/ijc.2910530614
Ravindranath, M., Muthugounder, S., Presser, N., Ye, X., Brosman, S., & Morton, D. (2005). Endogenous immune response to gangliosides in patients with confined prostate cancer. International journal of cancer. Journal international du cancer, 116, 368-377. doi:10.1002/ijc.21023
Saito, H., Miyatani, K., Kono, Y., Murakami, Y., Kuroda, H., Matsunaga, T., . . . Fujiwara, Y. (2017). Decreased Serum Concentration of Total IgG Is Related to Tumor Progression in Gastric Cancer Patients. Yonago acta medica, 60(2), 119-125. Retrieved from https://pubmed.ncbi.nlm.nih.gov/28701895
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502224/
Schulz, G., Cheresh, D. A., Varki, N. M., Yu, A., Staffileno, L. K., & Reisfeld, R. A. (1984). Detection of Ganglioside GD2 in Tumor Tissues and Sera of Neuroblastoma Patients. Cancer Res, 44(12 Part 1), 5914. Retrieved from http://cancerres.aacrjournals.org/content/44/12_Part_1/5914.abstract
Schulz, G., Cheresh, D. A., Varki, N. M., Yu, A., Staffileno, L. K., & Reisfeld., R. A. (1985). Detection of Ganglioside GD2 in Tumor Tissues and Sera of Neuroblastoma Patients. Cancer Res, 45(3), 1433. Retrieved from http://cancerres.aacrjournals.org/content/45/3/1433.2.abstract
Shparago, N., Zelazowski, P., Jin, L., McIntyre, T. M., Stuber, E., Peçanha, L. M., . . . Snapper, C. M. (1996). IL-10 selectively regulates murine Ig isotype switching. Int Immunol, 8(5), 781-790. doi:10.1093/intimm/8.5.781
Shurin, G. V., Shurin, M. R., Bykovskaia, S., Shogan, J., Lotze, M. T., & Barksdale, E. M., Jr. (2001). Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function. Cancer Res, 61(1), 363-369.
Simons, K., & Ikonen, E. (1997). Functional rafts in cell membranes. Nature, 387(6633), 569-572. doi:10.1038/42408
Thompson, K., Maltby, J., Fallowfield, J., McAulay, M., Millward-Sadler, H., & Sheron, N. (1998). Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis. Hepatology, 28(6), 1597-1606. doi:10.1002/hep.510280620
Trimaille, T., & Verrier, B. (2015). Micelle-Based Adjuvants for Subunit Vaccine Delivery. Vaccines, 3(4), 803-813. doi:10.3390/vaccines3040803
Tsai, Y.-C. (2013). A Prevalent Cancer Associated Glycan, Globo H Ceramide, Induces Immunosuppression by Reducing Notch1 Signaling. Journal of Cancer Science & Therapy, 05(07). doi:10.4172/1948-5956.1000215
Vijayanand, P., Seumois, G., Simpson, L. J., Abdul-Wajid, S., Baumjohann, D., Panduro, M., . . . Ansel, K. M. (2012). Interleukin-4 production by follicular helper T cells requires the conserved Il4 enhancer hypersensitivity site V. Immunity, 36(2), 175-187. doi:10.1016/j.immuni.2011.12.014
Villanueva-Cabello, T. M., Mollicone, R., Cruz-Muñoz, M. E., López-Guerrero, D. V., & Martínez-Duncker, I. (2015). Activation of human naïve Th cells increases surface expression of GD3 and induces neoexpression of GD2 that colocalize with TCR clusters. Glycobiology, 25(12), 1454-1464. doi:10.1093/glycob/cwv062
Yu, A. L., Gilman, A. L., Ozkaynak, M. F., London, W. B., Kreissman, S. G., Chen, H. X., . . . Children's Oncology, G. (2010). Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. The New England journal of medicine, 363(14), 1324-1334. doi:10.1056/NEJMoa0911123
Zhang, S., Zhang, H. S., Cordon-Cardo, C., Reuter, V. E., Singhal, A. K., Lloyd, K. O., & Livingston, P. O. (1997). Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens. International Journal of Cancer, 73(1), 50-56. doi:10.1002/(SICI)1097-0215(19970926)73:1<50::AID-IJC9>3.0.CO;2-0
Zhou, X., Su, Y.-X., Lao, X.-M., Liang, Y.-J., & Liao, G.-Q. (2016). CD19+IL-10+ regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4+ T cells to CD4+Foxp3+ regulatory T cells. Oral Oncology, 53, 27-35. doi:https://doi.org/10.1016/j.oraloncology.2015.11.003
Ziegler, S. F., Ramsdell, F., & Alderson, M. R. (1994). The activation antigen CD69. Stem Cells, 12(5), 456-465. doi:10.1002/stem.5530120502
|